Harrow Health is trading 5.29% down at $27.23 amid a broad market selloff.
- No clear company-specific announcement was found to explain the November 5 move; its next scheduled earnings report is November 9.
- Technology and AI-related shares are under pressure as investors reassess regulatory and investment risks after the midterm elections, pointing to broader market sentiment rather than a confirmed company-specific catalyst.